Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Apr 2022)

Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States

  • Erika J. Mejia,
  • Kimberly Y. Lin,
  • Oluwatimilehin Okunowo,
  • Katherine A. Iacobellis,
  • Susan E. Matesanz,
  • John F. Brandsema,
  • Carol A. Wittlieb‐Weber,
  • Hannah Katcoff,
  • Heather Griffis,
  • Jonathan B. Edelson

DOI
https://doi.org/10.1161/JAHA.121.024722
Journal volume & issue
Vol. 11, no. 8

Abstract

Read online

Background Duchenne and Becker muscular dystrophy are progressive disorders associated with cardiac mortality. Guidelines recommend routine surveillance; we assess cardiac resource use and identify gaps in care delivery. Methods and Results Male patients, aged 1 to 18 years, with Duchenne and Becker muscular dystrophy between January 2013 and December 2017 were identified in the IBM MarketScan Research Database. The cohort was divided into 80% for angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers was observed in 13.6% (419/3083) of total person years among patients in the 10 to 18 years group. Conclusions Children 10 to 18 years of age have higher rates of cardiac resource use compared with those <10 years of age. However, rates in both age groups fall short of guidelines. Opportunities exist to identify barriers to resource use and optimize cardiac care for patients with Duchenne and Becker muscular dystrophy.

Keywords